scholarly journals Detection of rare disease-related genetic variants using the birthday model

2018 ◽  
Author(s):  
Yael Berstein ◽  
Shane E. McCarthy ◽  
Melissa Kramer ◽  
W. Richard McCombie

AbstractMotivationExome sequencing is a powerful technique for the identification of disease-causing genes. A number of Mendelian inherited disease genes have been identified through this method. However, it remains a challenge to leverage exome sequencing for the study of complex disorders, such as schizophrenia and bipolar disorder, due to the genetic and phenotypic heterogeneity of these disorders. Although not feasible for many studies, sequencing large sample sizes (>10,000) may improve statistical power to associate more variants, while the aggregation of distinct rare variants associated with a given disease can make the identification of causal genes statistically challenging. Therefore, new methods for rare variant association are imperative to identify causative genes of complex disorders.ResultsHere we propose a method to predict causative rare variants using a popular probabilistic problem: The Birthday Model, which estimates the probability that multiple individuals in a group share the same birthday. We consider the probability and coincidence of samples sharing a variant akin to the chance of individuals sharing the same birthday. We investigated the parameter effects of our model, providing guidelines for its use and interpretation of the results. Using published data on autism spectrum disorder, hypertriglyceridemia in addition to a current case-control study on bipolar disorder, we evaluated this probabilistic method to identify potential causative variants. Several genes in the top results of the case-control study were associated with autism spectrum and bipolar disorder. Given that the core probability based on the birthday model is very sensitive to low recurrence, the method successfully tests the association of rare variants, which generally do not provide enough signal in commonly used statistical tests. Importantly, the simplicity of the model allows quick interpretation of genomic data, enabling users to select gene candidates for further biological validation of specific mutations and downstream functional or other studies.Availabilityhttps://github.com/yberstein/Birthday-Alqorithmhttp://labshare.cshl.edu/shares/mccombielab/www-data/Birthday-Algorithm/[email protected] (or [email protected])Supplementary informationSupplementary data are available online.

Author(s):  
Georgina M. Hosang ◽  
Helen L. Fisher ◽  
Rudolf Uher ◽  
Sarah Cohen-Woods ◽  
Barbara Maughan ◽  
...  

Autism ◽  
2014 ◽  
Vol 19 (6) ◽  
pp. 746-751 ◽  
Author(s):  
Rennan Y Du ◽  
Cynthia KY Yiu ◽  
Nigel M King ◽  
Virginia CN Wong ◽  
Colman PJ McGrath

2011 ◽  
Vol 58 (4) ◽  
Author(s):  
Amanat Ali ◽  
Mostafa I Waly ◽  
Yahya M Al-Farsi ◽  
Musthafa M Essa ◽  
Marwan M Al-Sharbati ◽  
...  

High serum homocysteine (Hcy) level is regarded as an indicator for impairment of folate-dependent methionine cycle and is associated with oxidative stress. In a case control study, we evaluated eighty 3-5 years old Omani children (40 diagnosed with Autism Spectrum Disorder and 40 their age and gender matched controls) for their fasting serum homocysteine levels as a biomarker of Autism Spectrum Disorder (ASD). Serum folate and vitamin B(12) status were also evaluated. The serum homocysteine was measured using an enzyme immunoassay (EIA) technique whereas folate and vitamin B(12) were measured using an automated random access immune-assay system. The results indicated that mean serum Hcy levels were significantly (P < 0.05) higher in autistic children (20.1 ± 3.3 µmol/L) as compared to controls (9.64 ± 2.1 µmol/L). Significantly (P < 0.05) lower serum folate (1.8 ± 0.4 µg/L) and vitamin B(12) (191.1 ± 0.9 pg/mL) levels were observed in autistic children as compared to controls (6.1 ± 0.6 µg/L and 288.9 ± 1.3 pg/mL, respectively). The levels of homocysteine in autistic children were also much higher as compared to normal reference values (5-15 µmol/L). The results suggest that high fasting serum homocysteine and low folate and vitamin B(12) levels could be used as clinical biomarkers for an early diagnosis and management of ASD.


2017 ◽  
Vol 47 (6) ◽  
pp. 568-578 ◽  
Author(s):  
Alessia Giuliano ◽  
Irene Saviozzi ◽  
Paolo Brambilla ◽  
Filippo Muratori ◽  
Alessandra Retico ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document